EXCLUSIVE LICENSE AND COMMERCIALIZATION AGREEMENTExclusive License and Commercialization Agreement • September 11th, 2013 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 11th, 2013 Company Industry JurisdictionPluristem Ltd. an Israel corporation, having its principal place of business at MATAM Advanced Technology Park, Building No. 5, Haifa 31905 Israel (“Pluristem”);and